Hospital information systems are increasingly used as part of decision support tools for planning at strategic, tactical and operational decision levels. Clinical pathways are an effective and efficient approach in standardising the progression of treatment, to support patient care and facilitate clinical decision making. This literature review proposes a taxonomy of problems related to clinical pathways and explores the intersection between Information Systems (IS), Operational Research (OR) and industrial engineering. A structured search identified 175 papers included in the taxonomy and analysed in this review. The findings suggest that future work should consider industrial engineering integrated with OR techniques, with an aim to improving the handling of multiple scopes within one model, while encouraging interaction between the disjoint care levels and with a more direct focus on patient outcomes. Achieving this would continue to bridge the gap between OR, IS and industrial engineering, for clinical pathways to aid decision support.
Introduction
Clinical pathways are an effective and efficient way to standardise the progression of treatment, which in effect can reduce the pressure and problems surrounding subject areas that decision makers need to address.
There is a vast scope for what can encompass the term clinical pathway, with numerous ways of formulating, approaching, and modelling them. As far as we are aware, the only literature reviews to explore specifically 'clinical pathways' in relation to OR is Elbattah and Molloy [61] and Erdogan and Tarhan [63] . Our paper differs from previous work as we provide a rigorous taxonomy to characterise an abundant work of literature around clinical pathways. Subsequently, we demonstrate the applicability of our taxonomy by classifying the research papers into the different categories.
This paper provides a general overview of the publications surrounding clinical pathways in healthcare, in addition to various detailed classifications of such publications. This enables clarity for any future publications surrounding clinical pathways to identify the current themes and methods used in the literature, and thus identify gaps.
For each figure that displays a key classification result, there is a respective table within Appendix II, which fully details the reference number for each paper within the category.
The remainder of the paper is structured as follows: Section 2 provides a definition of clinical pathways, Section 3 describes the search criteria, Section 4 discusses previous literature reviews. Section 5 then explores a sample of the selected papers to aid understanding of the taxonomy, Section 6 displays the taxonomy results for the literature and Section 7 closes the paper with a discussion and conclusion.
Definition
The first use of the term 'clinical pathway' was in 1985 by Zander, Etheredge, and Bower (1987) at the New England Medical Centre (De Bleser, Depreitere, de Waele, Vanhaecht, and Vlayen, 2006). Since then, the term has become more frequently used and mutated into multiple terms. For instance, deLuc et al. (2001) found 17 different terms which denoted the concept of 'clinical pathways', and discussed that the most common terms were 'care pathway', 'critical pathway', 'integrated care pathway' and 'care map'.
De Bleser, Depreitere, de Waele, Vanhaecht, and Vlayen (2006) conducted a literature review with the aim to 'survey the definitions used in describing the concept and to derive key characteristics of clinical pathways'. The authors found 84 different definitions of a clinical pathway between 2000 and 2003.
Kinsman, Rotter, James, Snow, and Willis (2010) conducted a literature review and developed detailed criteria for what should be classified as a clinical pathway and tested this against 260 papers. They developed the following criteria:
-The intervention was a structured multidisciplinary plan of care.
-The intervention was used to channel the translation of guidelines or evidence into local structures. -The intervention detailed the steps in a course of treatment or care in a plan, pathway, algorithm, guideline, protocol or other 'inventory of actions'. -The intervention had time-frames or criteriabased progression (that is, steps were taken if designated criteria were met). -The intervention aimed to standardise care for a specific clinical problem, procedure or episode of healthcare in a specific population.
If an intervention satisfied the first, and then any three of the remaining four criteria, then it was classified as a clinical pathway. This is a very detailed definition which clearly describes the features of a clinical pathway.
Search criteria
A structured search was conducted using the Scopus search engine restricting to years 1998-2018 (November). The keywords were specified to focus on clinical pathway and its main alternative terms as indicated by deLuc et al. (2001) : 'care pathway', 'critical pathway' and 'care map'. Two further terms were also included, namely 'anticipated recovery pathways' and 'patient pathway'.
The term 'patient flow' was not included in our search terms as this review is specifically interested in the structure of well-defined pathways, and patient flow typically relates to the general movement of patients.
We focus the search to journal publications from five categories in the Thomson-Reuters Journal Citation Report (JCR), and as a result only journal articles were returned by the search. The five subject categories are Anaesthesiology (AN), Health Policy and Services (HPS), Industrial Engineering (IE), Medical Informatics (MI) and Operations Research and the Management Sciences (OR/MS), each of which have an impact factor.
These categories were chosen to provide an overview of papers within the Operational Research (OR) area, in addition to highlighting the type of information that is being presented to other areas on this topic. Specifically, these five categories were chosen for the following reasons: The screening stage, as displayed in Figure 1 , consisted of analysing abstracts of the resulting papers from the search. Any papers that did not refer to a pathway or used only qualitative or statistical methods e.g., interviews or regression respectively, were excluded. The screening stage also excluded papers not available in English. The diagram highlights the use of a backward search, for which the same screening criteria as described above was applied. The final number of records included in the analysis is 175.
Previous research
Additionally to the 175 papers that were selected, our research revealed 11 papers of notable contribution and 27 literature reviews. All of these papers discuss clinical pathways and the techniques surrounding them, in some form. These are summarised and can be found in Appendix II, Tables A1 and A2, respectively. Concerning the 11 papers of notable contribution, these discussed guidelines, frameworks, case studies and I.T. artefacts that support clinical pathways.
Of the 27 review papers in Table A2 (Appendix II) , six consider process mining or data mining [38, 63, 78, 109, 135, 168] , seven consider simulation [2, 105, 132, 173, 175, 176, 208] and three consider stochastic modelling [59, 123, 213] .
There are seven papers that use the term 'clinical pathway', or its synonyms, in the search terms [61, 63, 132, 156, 173, 175, 189] and two papers use 'patient flow' in their search terms [109, 173] . These papers all consider clinical pathways, but most focus on a different primary topic.
There are only two reviews that concern clinical pathways specifically: Elbattah and Molloy [61] and Erdogan and Tarhan [63] .
Elbattah and Molloy [61] provide a comprehensive discussion of 22 papers concerning modelling and simulating clinical pathways. Our paper provides a different perspective from [61] as we provide a rigorous taxonomic approach to classifying many papers.
Although Erdogan and Tarhan [63] consider process mining as a primary topic, the amount of consideration and discussion around clinical pathways is vast, indicating 59 papers concerning clinical pathways. The systematic mapping method used is reflective of our method, however as clinical pathways are not the primary consideration, it does not fully consider a discussion of clinical pathways postdiscovery. With clinical pathways being the main focus of our paper, it differs from that of Erdogan and Tarhan [63] as we consider a holistic view on clinical pathways.
Exploration of a sample of papers
This section explores a sample of the papers for the purpose to aid understanding of the classifications in Section 6. These papers have been chosen so as to discuss the widest range of categories, using the smallest sample of papers.
The sample of papers are discussed briefly and their relevant categories are indicated in Table 1 Ajmi et al., [3] used Business Process Modelling Notation (BPMN) to model the workflows of the patient journey in a Paediatric Emergency Department. The aim was to identify bottlenecks and crowded situation indicators, with noting that delay occurs in the waiting time from the health care request. The study was integrated into the French National Research Agency (ANR) project, titled: 'Hospital: Optimization, Simulation and avoidance of strain (HOST)'.
Barbagallo et al., [14] used BPMN 2.0 to schedule operating room activity, by room and day through a waiting list database, and applied stochastic modelling to allow optimisation.
Bending et al., [19] used Monte Carlo sampling techniques to estimate the direct cost of bowel cancer services.
Chemweno et al., [35] developed a discrete event simulation on the stay of stroke patients in a stroke unit, specifically diagnosis, to investigate capacity and waiting times.
Du et al., [55] develop a new method of handling clinical pathway variances in Takagi-Sugeno (T-S) fuzzy neural networks (FNNs). Two cases concerning osteosarcoma preoperative chemotherapy are used to validate this method.
Huang et al., [97] used Latent Dirichlet Allocation (LDA) for the purpose of discovering the treatment patterns as a probabilistic combination of clinical activities. The method was then applied as part of experiments to careflow logs concerning intracranial haemorrhage and cerebral infarction.
Konrad et al., [107] developed a method to use message exchanges to automatically establish and compare a patient's path against a clinical pathway. The method has been applied to a case study in major joint replacement.
Langley et al., [116] developed a discrete event simulation model for the diagnosis of Tuberculosis (TB) to help provide policy makers with the information to decide which tools, and where, they should be implemented for maximum effectiveness. Lanzarone et al., [120] modelled the home care pathway using a Markov chain, where the future workload of each operator was of interest to support medium and short term resource planning. The model was developed as a simple software application, integrated into the current software used, which supports patient to operator assignment.
Michowski et al., [143] used a Bayesian Belief Network (BBN) to model the radical prostatectomy clinical pathway with an interest in patients length of stay being categorised as 'met' or 'delayed' given the patient's outcomes and activities. The research was implemented as an application.
Yang and Hwang [203] utilised clinical pathways, through data-mining using a Markov blanket filter, to facilitate automatic and systematic construction of an adaptable and extensible detection model of fraudulent and system abusive behaviour.
Classification of literature
This section discusses the taxonomy which classifies the literature, and provides summary statistics. Figure 2 displays the distribution of the papers across 21 years and shows that the number of publications considering clinical pathways has rapidly increased. This may reflect the growing demand for the use of clinical pathways in practice and thus the need for more in-depth research. Table 2 shows how the papers were distributed across the world. A paper was classified within a geographical area if it specifically stated that the data or hospital was within that area, or failing that, through any acknowledgements of a hospital in a specific area or the country of the first author was recorded. Table 2 shows how Europe has the greatest number of publications relating to clinical pathways, followed by Asia then America. This highlights that research into clinical pathways is of global interest.
General characteristics
This section concludes that research into clinical pathways is growing in popularity across the globe, year on year. There are 64 papers identified in the backward search, whose ISSN numbers do not relate to any of the five JCR categories, plus a further 16 papers in the backward search that appear to have no ISSN numberand thus also no JCR group. These are not included in Figure 3 .
Publication area
Two journals not included in the JCR categories published multiple papers identified in the search, these are Lecture Notes in Computer Science [20, 48, 85, 87, 98, 112, 179] and Studies in Health Technology and Informatics [5, 74, 76, 94, 121, 136, 210] .
It is apparent here that MI is the most popular JCR group followed by OR/MS. Although there were only a few papers in AN and IE, it is beneficial to capture these as they provide another perspective on clinical pathways.
This highlights the need to bridge the gap between MI with OR and IS methods. 
Obtaining the pathway
Obtaining the pathway is arguably one of the most important aspects of analysing clinical pathways. As presented in the selected papers, there are two common ways of obtaining this information: either data driven or through collaboration with those who interact with the pathway. There were many different ways of obtaining data described, including historic [143] , billing [85] , messages [107] and Electronic Medical Records [88] . Similarly, collaboration took on a number of different forms including, consulting with experts [17] , staff [10] , patients [136] and through observations [101] . Figure 4 explores how the information on the pathway was obtained. Forty-seven papers did not clearly specify how they obtained the data and have been classified as unspecified.
Eleven papers specifically stated other methods of collecting the information on the pathway, which are as follows - [19, 22, 41, 82, 116, 169] stated that the information was provided to them in some way, [79] through previous work (also consulted with experts and stakeholders), [128] online user input, and [21, 24, 60] used national guidelines.
The advantage of using data to inform the pathway is that the pathway is derived factually and objectively from actual occurrences of the pathway. The advantage of collaboration with staff and experts is that more information can be gathered about why certain decisions and possible variances from the pathway would occur. Therefore, it is recommended to consider both data driven and collaboration with staff when deriving the pathway, although we observe only 14 papers (8%) in our survey considered both aspects.
It is important to note that only 12 papers [3, 22, 52, 60, 73, 93, 96, 119, 120, 124, 143, 170] state that their research/product was implemented/informed policythis is only 6.9% of the papers surveyed. Previous reviews have found similar results in regards to implementation (e.g. Brailsford, Harper, Patel, & Pitt, 2009), and therefore this finding highlights the need for more implementation and evaluation. However, caution needs to be considered here as it is possible that some proposed recommendations were/will be eventually implemented but was outside the timeline of the publication.
Medical context

Condition area
The papers selected consider a variety of medical conditions which is either the main focus of the paper, or applied as case study/validation/explanation etc.
There are three condition categories: Acute, Chronic and Surgical, which have been adapted from Zhang, Padman, and Levin (2014). A description of the condition categories are as follows:
-Acute -'Acute conditions are severe and sudden in onset. This could describe anything from a broken bone to an asthma attack'. (Medline plus, 2018), stroke has been categorised as acute. The three condition areas have been further categories as either focus or applied:
-Focus -The system surrounding the medical condition was the main motivation for the paper. -Applied -The medical condition was considered as a case study or for validation purposes. Figure 5 shows the frequency of papers within each condition area.
Forty-nine papers are not included, as they did not specify a particular condition or considered multiple diagnosis-related groups (DRG).
Chronic conditions are slightly more frequent than acute conditions, and in all three categories, it is more frequent for the condition to be applied rather than the focus of the paper.
Care level
The medical care system is typically split into three sections, Primary, Secondary and Tertiary (NHS providers, 2018), which are as follows:
-Primary -First point of contact e.g. General Practitioner or dentist. -Secondary -Can either be elective or emergency care, also known as 'hospital and community care'. -Tertiary -Highly specialised treatment.
Two other levels can be considered -Home Care and Disease:
-Home Care -This is when care is provided to the patient at their own home. -Disease -This concerns understanding how the disease progresses and the care provided progresses alongside. Figure 6 shows the frequency at which each of the five care levels are considered, and displays that secondary care is considered most frequently.
Seven papers [11, 23, 45, 102, 115, 116, 142] consider when the patient is at home and then gets reintroduced into the system in some capacity.
It is important for these systems to work together to allow the patient a smoother journey on the pathway. Within Figure 6 , there are 42 papers that consider more than one care level -31 papers consider two levels, nine consider three levels. The interactions between these levels are displayed in Figure 7 .
There are also two papers that consider four levels [16, 145] (primary, secondary, tertiary and home care) which are not displayed in Figure 7 .
From Figure 7 , we can conclude that only a few papers consider three or more care levels, and therefore research is not providing the full holistic view of the pathway. It is recommended that, when appropriate, future work should make every effort to consider multiple care levels.
The interaction between condition area and care level can be considered, and is displayed in Figure 8 . Figure 8 shows that acute conditions are mainly considered at a secondary care level, whereas chronic conditions are roughly equally divided between secondary, tertiary or home care levels. This implies that chronic conditions have more range to consider different care levels.
Scope
Although a pathway always has a patient in mind, the scope of the focus on the pathway varied greatly from clinical, disease, department and hospital. This scope considers that although it is typical for the activities of concern to revolve around the patients, they may either not be required to be present, or it is the system around the patient that is of interest and not the patient movements themselves.
To explain this further, an example for each type of scope is now discussed.
• Bayer et al., [16] is categorised as 'Clinical', as they produce a simulation of the stroke care pathway where, although some activities do not require the patient to be present, the overall focus is on the patient themselves. • Michalowski et al., [143] is categorised as 'Disease', as the activities are related to the patients' health, e.g. temperature, pain at rest, vital signs etc. • van de Klundert et al., [187] is categorised as 'Department', as they define an activity as 'an atomic unit of care delivered to the patient, as meaningful to execute or record the care'. They also state that 'Although we will not explicitly model it, patient need not be present for each of the activities (consider e.g. lab tests).. • Arnolds and Gartner [8] is categorised as 'Hospital', as they focus on improving hospital layout planning by using clinical pathway mining. Figure 9 displays the frequency of papers in each scope category.
There were only five cases where more than one scope was considered [13, 43, 102, 128, 211] . In all of these cases, both clinical and disease scopes were considered. This was due to the clinical activities being dependent on the progress of disease at particular points e.g. Liu et al., [128] investigate the readmission risk percentage based on the patient activities which differ depending on the diagnosis of the disease.
From the selected literature, it appears that considering more than one scope area is difficult to carry out in a realistic format, which is not in the form of dummy or pseudo activities. It is believed that this is a limitation of the types of methods ( Figure 10 and Table A9 ) that are considered and thus suggests an opportunity for further work.
Technical context
Method
There are many methods that can be used for clinical pathways, they have been categorised into four groups: Stochastic Modelling, Data Mining or Machine Learning, Simulation, and Optimisation and Heuristics. Further description of what methods are included, but not limited to, in each group are as follows:
• Stochastic Modelling -Includes Markov [40] and queueing [190] methods. • Data Mining or Machine Learning -Includes Bayesian techniques and Bayesian Belief Networks [143] , machine learning [76] and visualisation [20] . • Simulation -Includes discrete-event [79] , agent based [129] , Monte Carlo [7] and system dynamics [142, 191] . • Optimisation and Heuristics -Includes genetic algorithm [57] , and mathematical programming, including dynamic [187] , mixed-integer [75] , mixed-integer linear [31] and goal [167] . Figure 10 displays the frequency of papers in each method group, and indicates that data mining or machine learning was the most popular method to be applied, closely followed by simulation.
Eighteen papers were identified as using multiple methods, 16 of those papers applied two methods and two papers applied three methods. This is just 10% of the total selected papers. The combinations of methods applied are displayed in Figure 11 .
The majority of these papers use data mining or machine learning along with one other method, and thus shows that those papers using multiple techniques are bridging the gap between OR, IS and industrial engineering. The interaction between method and condition can be considered, and is displayed in Figure 12 . Figure 12 shows that data mining or machine learning more frequently considers applied conditions, and simulation more frequently has the condition as the focus of the paper, in all three condition areas.
Furthermore, six papers [3, 14, 24, 151, 164, 202 ] discuss the use of 'Business Process Modeling Notation' (BPMN). BPMN is the use of graphical notation for the purpose of illustrating business processes.
Fourteen papers [1, 11, 13, 18, 42, 81, 87, 100, 120, 127, 128, 144, 157, 210] indicate that they develop a type of IT artefact that can be implemented to support the clinical pathways under consideration. These papers are also bridging the gap between OR, IS and industrial engineering.
This highlights that to continue bridging the gap between OR, IS and industrial engineering future work should consider Data Mining and Machine Learning alongside OR techniques, and integrate them whenever possible.
Investigating area
The literature discusses three ways of investigating the pathway: mapped, modelled and improved. A paper is classed as mapping a pathway if it provides some information and process of initially defining the pathway, modelling if it created a model of that pathway, and improved if some scenario analysis, recommendation or support for improvement was made. It is possible for a paper to consider more than one of these investigation areas. Figure 13 displays the frequency of papers considering each investigation area.
The two papers that were categorised exclusively as improving discussed the development of a web-based tool to aid with clinical pathway usage, and thus did not map or model the pathway. There are no papers that both map and improve the pathway, without also modelling it. This is intuitive, as a model cannot be improved if it was not modelled. Figure 13 concludes that all three investigation areas are important when considering clinical pathways, and applying all three provides a more complete picture. It is suggested that future work place more focus/importance on improving the pathway and its related outcomes, as this is one of the key advantages of using an OR technique, and can aid decision making.
The investigation area that is considered is related to the type of method used, as displayed in Figure 14 . Figure 14 displays that the most frequently used techniques to map a pathway are data mining and machine learning, whereas simulation is the most Figure 11 . Frequency of papers applying two methods. popular technique for considering modelling or improving a pathway.
Outcome
The outcome, main decision variable or indication factor for performance of interest can lead the whole direction of research. The outcomes considered in the literature can be grouped into six categories. A description of the categories is as follows:
• Legal: Papers including factors of a legal matter, such as fraud or medical negligence. • Patient Progression: Any factor related to the patient specifically e.g. Quality Adjusted Life Years (QALY), survival, disease progression/ management. • Cost: This category includes any paper related to cost. • Resource: Any factor considered to be a resource e.g. MRI Scanner, capacity, staffing levels. • Time: Any factor related to time is included in this category e.g. length of stay, scheduling, waiting times and travel times. • Pathway Mapping: Papers that aimed to establish and map the pathway, including pathway variances are included here. Figure 15 shows the frequency of papers amongst these outcomes. Pathway mapping is the most frequent category, while (excluding legal) patient progression is the least frequent. This may be concerning as the patients are those whose health and lives are effected by all of the outcome factors, and thus should be at the forefront of any outcome considered. Therefore it is recommended that more emphasis should be placed on patient outcomes in a more direct manner.
Thirty-seven papers considered multiple outcomes, where 32 considered two outcomes, and four considered three outcomes (Figure 16 ). Figure 16 shows that time and resource are most frequently considered together, and it is rare to find papers considering more than two outcome measures.
Only one paper considered four outcomes [145] (time, resource cost and patient progression), which is not displayed in Figure 16 .
Although an outcome is often regarded as the final result of any research, this also has an impact on the areas surrounding constructing the approach, such as the method or scope considered. Figure 17 shows the frequencies of the cross analysis between outcome and method. This displays that data mining or machine learning is most frequently used for pathway mapping, whereas simulation is most frequently used to measure cost, resource or time outcome measures. Figure 18 shows the frequencies of the cross analysis between outcome and scope. It displays that a clinical scope is most frequently used for pathway mapping, whereas resource and time are approximately equally split between hospital and departmental scope. As an example of the interaction between outcome factor and scope, Barone et al., [15] considered departmental scope in relation to time, resource and cost outcome factors through simulation to plan daily nurse requirements in a stroke unit. In contrast, Uzun Jacobson et al., [186] considered a clinical scope in relation to patient progression outcomes, through discreteevent simulation of hyper-acute stroke care, concerning the percentage of patients receiving thrombolysis.
Planning decisions
Hulshof, Kortbeek, Boucherie, Hans, and Bakker (2012) describes a taxonomic classification of planning decisions in health care in OR/MS. This taxonomy separates the papers into three decision levels: Strategic, Tactical and Operational. A brief description of the decision levels are as follows, however a formal definition of the three decision levels can be found in Hulshof et al. (2012) .
-Strategic planning involves structural decision making of the design, dimensioning and development of healthcare. This typically has a long planning horizon e.g. location planning and staffing levels. -Tactical planning organises the operation of the healthcare delivery system, typically on a midterm planning horizon, e.g. staff shift scheduling.
-Operational planning executes the routine planning of the healthcare delivery system on a short-term planning horizon e.g. patient-toappointment scheduling. Figure 19 shows the frequency of the papers in each decision level. This highlights that strategic decisions are considered most frequently out of the three decision levels, however more often than not, there is no decision to consider. Three papers state that they consider more than one decision level. Barbagallo et al., [14] states that it considers both strategic and tactical decisions, Landa et al., [113] considers tactical and operational decisions and Burdett et al., [31] consider strategic and operational decisions.
This shows that the use of clinical pathways can be used across all the decision levels, from day-to-day decisions to wider policy decisions. Hulshof et al. (2012) applies the taxonomy for those papers in the OR/MS JCR category, however in this paper we have considered five JCR groups. The cross analysis between decision level and JCR category can be seen in Figure 20 . Figure 20 shows that the decision levels are in fact spread across the five JCR groups, which shows that the Hulshof et al. (2012) decision level taxonomy can be applied to more than just the OR/MS JCR group.
The decision level does impact other aspects of the research that have been previously discussed. Therefore, a cross analysis between the decision level with scope, method, and outcome will now be considered. The cross analyses between decision level and method, and decision level and outcome, both help to explain why such a high number of papers refrain from considering a decision level.
Firstly, Figure 21 considers the interaction between decision level and scope of the research.
There appears to be an even dispersion of scope across the three decision levels, with strategic being most popular in clinical and disease scope than the other two decision levels. Considering the papers that had no decision level, these are most often concerning clinical scope, but there is also an equal spread between the three remaining scope areas.
Secondly, Figure 22 considers the interaction between decision level and method.
This shows that simulation is most frequently used across all three decision levels. The interaction between data mining or machine learning and no decision was most commonly observed. This can be explained as this method is most frequently used for mapping a pathway ( Figure 14 ) for reasons such as defining the pathway, and therefore would have no decision associated with this.
The conclusion drawn from the above analyses can be supported when considering the interaction between decision level and outcome measure (Figure 23) . Figure 23 shows that no decision most frequently occurs when the outcome is pathway mapping. Again, all of the outcome measures have an even distribution across all three decision levels, with strategic decisions being slightly more prominent.
Conclusions
There is a vast scope for what can encompass the term clinical pathway, with numerous ways of formulating, approaching, and modelling these. This paper provides a general overview of the publications surrounding clinical pathways in healthcare. A number of taxonomies have been developed, providing a detailed classification of the publications. This enables clarity for any future publications surrounding clinical pathways to identify the current themes and methods used in the literature, and thus identify gaps. Section 6 discusses the taxonomy, analysed frequencies, and provided cross analysis where appropriate. Some areas of recommended focus for future work were highlighted in the discussion, and are summarised as follows: -Careful consideration of publication area, to ensure the information is reaching all communities involved. -Derive the pathway from both data and collaboration with staff. -Consider a medical condition, whether in focus or applied application, as this better fits with clinical pathways specifically. -Include as many care levels as possible (when appropriate) to encourage communication and awareness between them. -Improve the methods used to allow for multiple types of scope to be considered together. Following these recommendations should lead to a more thorough study of the whole clinical pathway. The paper from Monks et al., [145] presents a methodology for simulation modelling of stroke care systems, and captures many of the same recommendations as discussed above, and thus is a notable example of what future research should aim to aspire to.
The inclusion of the cross analysis between the identified taxonomy areas allows those who are considering research to more carefully consider the combinations of these areas, both for quality, appropriateness and discovering areas in which there is a lack of research.
In conclusion, future work should consider industrial engineering and IS integrated with OR techniques, with an aim to improve the handling of multiple scope within one model, while encouraging interaction between the previously disjoint care levels, with a more direct focus on patient outcomes. Achieving this would continue to bridge the gap between OR, IS and industrial engineering, while improving methods for clinical pathways to aid in supporting decisions.
It is important to continue research into clinical pathways, as it is a subject of global interest, whose popularity continues to grow over time.
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Outcome
Pathway Mapping [1, 4, 5, 13, 20, 33, 37, 42, 47, 54-56, 58, 62, 70, 71, 81-83, 86-99, 107, 112, 114, 115, 121, 126-128, 136, 138-140, 149, 154, 157, 162, 164, 171, 172, 177-179, 183, 184, 187, 188, 192, 195, 197-202, 206, 210 , 211] Time [3, 8, 10, 12, 15, 16, 18, 23, 29-32, 34-36, 41, 46, 50, 52, 57, 62, 64, 67, 68, 72, 74, 75, 80, 85, 94, 100, 108, 110, 118, 129, 133, 138, 141-143, 145-147, 151, 160, 161, 163, 165-167, 169, 182, 185, 190, 204, 205, 212] Resource [3, 7, 10, 14, 15, 17, 25, 27, 29, 31, 32, 35, 36, 46, 52, 64, 75, 76, 100, 113, 118-120, 142, 145, 148, 151-153, 160, 161, 163, 170, 182, 191, 204 ] Cost [9, 11, 14, 15, 19, 21, 22, 40, 43, 45, 53, 60, 73, 79, 101, 111, 117, 118, 125, 133, 134, 138, 145, 158, 166, 167, 209] Patient Progression [24, 29, 39, 40, 45, 48, 49, 51, 60, 79, 86, 101-104, 107, 116, 122, 124, 131, 139, 144, 145, 150, 186, 196 ] Legal [66, 203] Table A14 . Planning decision level taxonomy.
Decision Level Strategic [3, 8, 9, 14, 16, 19, 22, 25, 27, 29, 31, 32, 39, 41, 43, 45, 46, 49, 52, 60, 64, 67, 72, 73, 80, 101-103, 111, 115, 116, 136, 158, 165-167, 170, 182, 190, 191 ] Tactical [7, 10, 12, 14, 30, 34-36, 68, 74, 76, 79, 86, 108, 113, 117, 141, 142, 145, 147, 148, 161, 163] Operational [15, 17, 18, 31, 53, 57, 75, 90, 110, 113, 118-120, 134, 143, 146, 150, 153, 160, 169, 186, 212] No Decision [1, 4, 5, 11, 13, 20, 21, 23, 24, 33, 37, 40, 42, 47, 48, 50, 51, 54-56, 58, 62, 66, 70, 71, 81-83, 85, 87-89, 91-100, 104, 107, 112, 114, 121, 122, 124-129, 131, 133, 138-140, 144, 149, 151, 152, 154, 157, 162, 164, 171, 172, 177-179, 183-185, 187, 188, 192, 195-206, 209-211] 
